Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M KORMAN

Showing results (161-170 of 206) with videos related to

Pageof 21
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2013
Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemiaN E Holmes, J D Turnidge, W J Munckhof, et al.
Journal of the American Academy of Dermatology|July 29, 2023
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and managementBrian M Wei, Lindy P Fox, Benjamin H Kaffenberger, et al.
International Journal of Antimicrobial Agents|August 3, 2020
Identification and characterisation of fosfomycin resistance in Escherichia coli urinary tract infection isolates from AustraliaShakeel Mowlaboccus, Denise Daley, Stanley Pang, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2015
Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14Daniel R Knight, Steven Giglio, Peter G Huntington, et al.
The Journal of Infectious Diseases|July 12, 2011
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrationsNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2012
Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and deathSharon C-A Chen, Monica A Slavin, Christopher H Heath, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2013
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattiiSharon C-A Chen, Tony M Korman, Monica A Slavin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2014
Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strainSze K Lim, Rhonda L Stuart, Kate E Mackin, et al.
The Lancet Regional Health. Western Pacific|February 13, 2025
Genomic interrogation of invasive group A <i>Streptococcus</i> (iGAS) epidemiology and COVID-19 impacts in Victoria, Australia: a 6-year retrospective studyJacqueline M Morris, Jake A Lacey, Kerrie Stevens, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 16, 2017
Herpes simplex virus-2 transmission following solid organ transplantation: Donor-derived infection and transplantation from prior organ recipientsNenad Macesic, Iain J Abbott, Matthew Kaye, et al.
Pageof 21

Showing results (161-170 of 206) with videos related to

Sort By:
Pageof 21
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2013
Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemiaN E Holmes, J D Turnidge, W J Munckhof, et al.
Journal of the American Academy of Dermatology|July 29, 2023
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and managementBrian M Wei, Lindy P Fox, Benjamin H Kaffenberger, et al.
International Journal of Antimicrobial Agents|August 3, 2020
Identification and characterisation of fosfomycin resistance in Escherichia coli urinary tract infection isolates from AustraliaShakeel Mowlaboccus, Denise Daley, Stanley Pang, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2015
Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14Daniel R Knight, Steven Giglio, Peter G Huntington, et al.
The Journal of Infectious Diseases|July 12, 2011
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrationsNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2012
Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and deathSharon C-A Chen, Monica A Slavin, Christopher H Heath, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2013
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattiiSharon C-A Chen, Tony M Korman, Monica A Slavin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2014
Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strainSze K Lim, Rhonda L Stuart, Kate E Mackin, et al.
The Lancet Regional Health. Western Pacific|February 13, 2025
Genomic interrogation of invasive group A <i>Streptococcus</i> (iGAS) epidemiology and COVID-19 impacts in Victoria, Australia: a 6-year retrospective studyJacqueline M Morris, Jake A Lacey, Kerrie Stevens, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 16, 2017
Herpes simplex virus-2 transmission following solid organ transplantation: Donor-derived infection and transplantation from prior organ recipientsNenad Macesic, Iain J Abbott, Matthew Kaye, et al.
Pageof 21